StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UBS Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)
November 15, 2021 4:45 AM
UBS analyst Michael Leuchten ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Intl Ratings
Next Articles
AstraZeneca (AZN) Has Supplied Two Billion Doses of COVID-19 Vaccine in 11 Months
November 16, 2021 6:00 AM
AstraZeneca (AZN) Reports Positive Phase IIa Results from the EPICCURE Trial
November 15, 2021 8:24 AM